Liver Cirrhosis with Ascites

• EMA approval · 2026-07-14
  EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH

  EMA has authorized Qaialdo, a spironolactone product by Lipomed GmbH, for several conditions including edema, heart failure, liver cirrhosis…

• CLINICAL_TRIALS trial_result · 2023-05-09
  Clinical Trial Update: To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites [Phase 3]

  A Phase 3 clinical trial investigating the effect of nonselective beta blockers in advanced liver disease with ascites has completed.

• FDA approval · 2019-11-14
  FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals Inc., enabling continued marketing of the product and …

• FDA approval · 2011-01-27
  FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)

  FDA approved a supplemental application for furosemide from Ipca Laboratories Limited under an ANDA, signaling approval of changes to the ge…

• CLINICAL_TRIALS research · 2008-04-11
  Clinical Trial Update: Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction [Phase 2]

  A Phase 2 clinical trial comparing albumin dosing regimens of 4 g/L versus 8 g/L to prevent post-paracentesis circulatory dysfunction in pat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.